Transparency Market Research Global In-vitro Colorectal Cancer Screening Tests Market to reach US$980.6 mn by 2023; Asia Pacific to Register Highest Growth Rate Published Date 15-Sep-2015 95 Page Report Buy Now Request Sample Press Release http://www.transparencymarketresearch.com/pressrelease/in-vitro-colorectal-cancerscreening-tests-market.htm Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com [email protected] Radiopharmaceuticals Market REPORT DESCRIPTION Global In-vitro Colorectal Cancer Screening Tests Market to reach US$980.6 mn by 2023 According to a new market report published by Transparency Market Research In-vitro Colorectal Cancer Screening Tests Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023”, the global in-vitro colorectal cancer screening tests market was valued at US$494.1 mn in 2014 and is anticipated to reach US$980.6 mn by 2023, expanding at a CAGR of 7.5% during the forecast period from 2015 to 2023. Increase in the geriatric population, rise in prevalence of colorectal cancer, high prevalence of inflammatory bowel disease, and easy access to health care facilities contribute to the growth of the in-vitro colorectal cancer screening tests market. Geographically, the in-vitro colorectal cancer screening tests market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Rest of the World. North America accounted for the largest share of the in-vitro colorectal cancer screening tests market in 2014, followed by Europe. In terms of revenue, North America was the largest market for in-vitro colorectal cancer screening tests, and accounted for a share of over 35.0% of the global market in 2014. Dominance of North America has been attributed to rise in health awareness among the population, the scope of expansion of clinical laboratories, rapid introduction of advanced technological implementations, and increase in incidence of colorectal cancer. Additionally, rise in geriatric population and availability of various reimbursement policies from public and private health insurance firms fuel the growth of the in-vitro colorectal cancer screening tests market in North America. The U.S. dominated the in-vitro colorectal cancer screening tests market in North America. Positive initiatives by the U.S. Government are anticipated to boost market growth during the forecast period. Enquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3698 Europe was the second largest market for in-vitro colorectal cancer screening tests in 2014. Major countries in Europe such as the U.K., Germany, France, Russia, Spain, Italy, Switzerland, the Netherlands, Portugal, and Belgium accounted for a majority share of the in-vitro colorectal cancer screening tests market in Europe in 2014. Key factors driving the growth of the market in Europe are rising demand for technologically advanced products, easy adoption of screening tests, increasing geriatric population, and growing health care awareness. Germany is considered to be a promising market for 2 Transparency Market Research Radiopharmaceuticals Market in-vitro colorectal cancer screening tests due to increase in acceptance of technologically advanced products, rise in geriatric population, growth in incidence of colorectal cancer, and cost-effective screening tests. Asia Pacific was the third largest market for in-vitro colorectal cancer screening tests in terms of revenue in 2014. However, the market in the region is expected to expand at a CAGR of 18.6% during the forecast period from 2015 to 2023. Factors attributed to the rapid growth of the in-vitro colorectal cancer screening tests market in Asia Pacific are constant rise in the geriatric population, increase in the prevalence of colorectal cancer and inherited syndrome, and surge in health care expenditure. Rest of Asia Pacific dominated the in-vitro colorectal cancer screening tests market in Asia Pacific due to developing health care infrastructure and rise in awareness related to colorectal cancer. Rest of Asia Pacific comprises South Korea, Malaysia, Singapore, Indonesia, Thailand, Vietnam, Taiwan, and the Philippines, among other countries. The in-vitro colorectal cancer screening tests market in Latin America and Rest of the World is expected to expand at moderate growth rate during the forecast period due to the gradually improving financial stability, high prevalence of colorectal cancer, and introduction of non-invasive screening tests in the region. Abbott Molecular, Inc., Alere, Inc., Beckman Coulter, Inc., Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA, CML Healthcare, Inc., and BioTime, Inc. are the major players operating in the global in-vitro colorectal cancer screening tests market. Quest Diagnostics and Beckman Coulter, Inc. are the market leaders. TABLE OF CONTENT Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology Chapter 2 Executive Summary 2.1 Global In-vitro Colorectal Cancer Screening Tests Market, Estimates and Forecast, By Revenue, 2015–2023 (US$ Mn) 2.2 Global Market Share by Geography, 2014 and 2023 3 Transparency Market Research Radiopharmaceuticals Market 2.3 Global In-vitro Colorectal Cancer Screening Tests Market, by Test Type 2014 (US$ Mn) 2.4 In-vitro Colorectal Cancer Screening Tests Market Snapshot Chapter 3 In-vitro Colorectal Cancer Screening Tests Market– Industry Analysis 3.1 Introduction 3.2 Epidemiology – In-vitro Colorectal Cancer Screening 3.3 Market Drivers 3.3.1 Increase in demand for rapid and non-invasive diagnostic tools and techniques 3.3.2 High prevalence of inherited syndromes, diabetes, and others 3.3.3 Increased awareness of colorectal cancer and health care expenditure globally 3.4 Restraints 3.4.1 Stringent and ambiguous regulatory environment 3.4.2 Reimbursement challenges 3.5 Opportunity 3.5.1 Shift from invasive to non-invasive diagnostic techniques 3.5.2 Increase in new technology in molecular-based diagnostic tests 3.6 Porter’s Five Forces Analysis 3.7 Event Impact Analysis – In-Vitro Colorectal Cancer Screening Tests Market 3.8 Market Share – In-Vitro Colorectal Cancer Screening Tests Market (2014) (%) 3.9 Market Attractiveness Analysis – In-Vitro Colorectal Cancer Screening Tests Market Chapter 4 Market Segmentation – By Tests Type 4.1 Introduction 4.2 Global Fecal Occult Blood Tests Market , 2015–2023 (US$ Mn) 4.2.1 Global Guaiac FOB Stool Test Market, 2015–2023 (US$ Mn) 4.2.2 Global Immuno-FOB Agglutination Test Market, 2015–2023 (US$ Mn) 4.2.3 Lateral Flow Immuno-FOB Test Market, 2015-2023(US$ Mn) 4.2.4 Immuno-FOB ELISA Test Market, 2015-2023(US$ Mn) 4.3 Stool Biomarker Tests Market , 2015–2023 (US$ Mn) 4.3.1 ColoGuard Test Market, 2015–2023 (US$ Mn) 4.3.2 M2-PK Stool Test Market, 2015–2023 (US$ Mn) 4.3.3 Other Tests Market, 2015–2023 (US$ Mn) 4.4 Blood Biomarker Tests Market, 2015–2023 (US$ Mn) 4 Transparency Market Research Radiopharmaceuticals Market 4.4.1 ColonSentry Test Market, 2015–2023 (US$ Mn) 4.4.2 ColoVantage Test Market, 2015–2023 (US$ Mn) 4.4.3 Epi proColon Test Market, 2015–2023 (US$ Mn) 4.4.4 mS9 Test Market, 2015–2023 (US$ Mn) 4.4.4 Other tests Market, 2015–2023 (US$ Mn) Chapter 5 Pipeline Analysis 5.1 Pipeline Analysis In-Vitro Colorectal Cancer Screening Market Chapter 6 Market Segmentation – Regional Analysis 6.1 Regional Overview – In-vitro Colorectal Cancer Screening Tests Market 6.2 North America In-vitro Colorectal Cancer Screening Tests Market, 2015–2023 (US$ Mn) 6.3 Europe In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 6.4 Asia Pacific In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 6.5 Latin America In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 6.6 RoW In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) Chapter 7 Recommendations Chapter 8 Company Profiles 8.1 Abbott Laboratories, Inc. 8.2 Alere, Inc. 8.3 Beckman Coulter, Inc. 8.4 Sysmex Corporation 8.5 Quest Diagnostics, Inc 8.6 Epigenomics AG 8.7 Exact Sciences Corporation 8.8 BioTime, Inc. 8.9 CML Healthcare, Inc. 8.10 Novigenix SA About Us 5 Transparency Market Research Radiopharmaceuticals Market Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/ 6 Transparency Market Research

According to a new market report published by Transparency Market Research In-vitro Colorectal Cancer Screening Tests Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023”, the global in-vitro colorectal cancer screening tests market was valued at US$494.1 mn in 2014 and is anticipated to reach US$980.6 mn by 2023, expanding at a CAGR of 7.5% during the forecast period from 2015 to 2023.